X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ORCHID PHARMA LTD - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD ORCHID PHARMA LTD ALEMBIC LTD/
ORCHID PHARMA LTD
 
P/E (TTM) x 75.5 -0.8 - View Chart
P/BV x 2.8 0.5 514.5% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ALEMBIC LTD   ORCHID PHARMA LTD
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
ORCHID PHARMA LTD
Sep-13
ALEMBIC LTD/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs53194 27.2%   
Low Rs2935 83.7%   
Sales per share (Unadj.) Rs4.7276.5 1.7%  
Earnings per share (Unadj.) Rs8.8-79.2 -11.1%  
Cash flow per share (Unadj.) Rs9.0-43.5 -20.7%  
Dividends per share (Unadj.) Rs0.150-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs27.753.9 51.4%  
Shares outstanding (eoy) m267.0370.45 379.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x8.70.4 2,100.1%   
Avg P/E ratio x4.7-1.4 -323.7%  
P/CF ratio (eoy) x4.6-2.6 -173.0%  
Price / Book Value ratio x1.52.1 69.7%  
Dividend payout %1.70-   
Avg Mkt Cap Rs m10,9628,067 135.9%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2382,527 9.4%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m1,26019,477 6.5%  
Other income Rs m264407 64.8%   
Total revenues Rs m1,52419,884 7.7%   
Gross profit Rs m831,103 7.5%  
Depreciation Rs m612,519 2.4%   
Interest Rs m05,227 0.0%   
Profit before tax Rs m285-6,236 -4.6%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-32511 -6.3%   
Tax Rs m6-125 -4.9%   
Profit after tax Rs m2,343-5,580 -42.0%  
Gross profit margin %6.65.7 116.1%  
Effective tax rate %2.12.0 106.6%   
Net profit margin %185.9-28.7 -648.8%  
BALANCE SHEET DATA
Current assets Rs m1,68911,014 15.3%   
Current liabilities Rs m48632,060 1.5%   
Net working cap to sales %95.4-108.1 -88.3%  
Current ratio x3.50.3 1,011.1%  
Inventory Days Days21795 228.7%  
Debtors Days Days8134 241.5%  
Net fixed assets Rs m1,62429,440 5.5%   
Share capital Rs m534705 75.8%   
"Free" reserves Rs m5,9602,043 291.8%   
Net worth Rs m7,4043,800 194.8%   
Long term debt Rs m1049,018 1.2%   
Total assets Rs m8,01046,510 17.2%  
Interest coverage x950.7-0.2 -492,267.1%   
Debt to equity ratio x02.4 0.6%  
Sales to assets ratio x0.20.4 37.6%   
Return on assets %29.3-0.8 -3,848.6%  
Return on equity %31.6-146.9 -21.5%  
Return on capital %31.3-3.7 -837.8%  
Exports to sales %2.937.9 7.8%   
Imports to sales %28.922.6 127.6%   
Exports (fob) Rs m377,378 0.5%   
Imports (cif) Rs m3644,406 8.3%   
Fx inflow Rs m377,513 0.5%   
Fx outflow Rs m3655,649 6.5%   
Net fx Rs m-3281,865 -17.6%   
CASH FLOW
From Operations Rs m3461,682 20.6%  
From Investments Rs m-48-9,860 0.5%  
From Financial Activity Rs m-3016,644 -4.5%  
Net Cashflow Rs m-3-1,535 0.2%  

Share Holding

Indian Promoters % 64.0 32.3 198.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 4.6 4.3%  
FIIs % 9.7 3.3 293.9%  
ADR/GDR % 0.0 4.6 -  
Free float % 26.1 55.3 47.2%  
Shareholders   54,701 84,811 64.5%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   FDC LTD.  UNICHEM LAB  CIPLA  AJANTA PHARMA  SUVEN LIFE  

Compare ALEMBIC LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 21, 2017 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS